MedTrace Logo

Ferritin Screening And IRon Treatment for Maternal Anemia and FGR Prevention Trial

NCT04228627 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2026-01-15

No results posted yet for this study

Summary

Prevalence of anemia in Asia is more than 50%. All woman who book for antenatal care with non-anaemic iron deficiency (NAID) can be offered therapeutic doses of parentral iron, as a directly observed complete therapy, to prevent of maternal anaemia and fetal growth restriction. The investigators will compare this intervention with usual care in a multicentre randomised trial.

Conditions

  • Iron Deficiency (Without Anemia)
  • Pregnancy Related

Interventions

DRUG

Parentral Iron

Correction of Iron stores without anaemia

Sponsors & Collaborators

  • Allama Iqbal Medical College

    collaborator OTHER

  • Universidad de Granada

    collaborator OTHER

  • Fatima Jinnah Medical University

    collaborator OTHER

  • Services Institute of Medical Sciences, Pakistan

    lead OTHER_GOV

Principal Investigators

  • TAYYIBA Wasim · Services Institute of Medical Sciences, Pakistan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-14
Primary Completion
2024-01-30
Completion
2024-02-28

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04228627 on ClinicalTrials.gov